32824173|t|The Addition of Intravenous Propofol and Ketorolac to a Sevoflurane Anesthetic Lessens Emergence Agitation in Children Having Bilateral Myringotomy with Tympanostomy Tube Insertion: A Prospective Observational Study.
32824173|a|The aim of this prospective observational study was to determine if children undergoing bilateral myringotomy and tympanostomy tube insertion with a sevoflurane anesthetic plus intravenous propofol and ketorolac experienced a lower incidence of emergence agitation than those receiving a sevoflurane anesthetic alone. Duration of procedure, length of stay in post-anaesthesia care and level of nursing effort required to care for patients were also assessed. In this study, 49 children younger than 13 years of age received a sevoflurane anesthetic. Fifty-one percent of these patients also received a single injection of propofol 1 mg/kg and ketorolac 0.5 mg/kg at the end of the procedure. Patients were assessed for emergence agitation using the Pediatric Anesthesia Emergence Delirium scale in the post-anaesthesia care unit. Four children receiving a sevoflurane anesthetic alone experienced emergence agitation, while no children receiving propofol and ketorolac experienced emergence agitation (p = 0.05). The length of stay until discharge from the hospital was 6.98 min longer for patients receiving propofol and ketorolac but did not reach statistical significance (p = 0.23). Nurses reported greater ease in caring for patients receiving the propofol and ketorolac injection (recovery questionnaire score 4.50 vs. 3.75, p = 0.002). In this study, adding a single injection of intravenous propofol and ketorolac to the end of a brief sevoflurane anesthetic for bilateral myringotomy with tube insertion was associated with a lower incidence of emergence agitation without significantly increasing the time to discharge from the hospital.
32824173	28	36	Propofol	Chemical	MESH:D015742
32824173	41	50	Ketorolac	Chemical	MESH:D020910
32824173	56	67	Sevoflurane	Chemical	MESH:D000077149
32824173	87	106	Emergence Agitation	Disease	MESH:D000071257
32824173	366	377	sevoflurane	Chemical	MESH:D000077149
32824173	406	414	propofol	Chemical	MESH:D015742
32824173	419	428	ketorolac	Chemical	MESH:D020910
32824173	462	481	emergence agitation	Disease	MESH:D000071257
32824173	505	516	sevoflurane	Chemical	MESH:D000077149
32824173	647	655	patients	Species	9606
32824173	743	754	sevoflurane	Chemical	MESH:D000077149
32824173	794	802	patients	Species	9606
32824173	839	847	propofol	Chemical	MESH:D015742
32824173	860	869	ketorolac	Chemical	MESH:D020910
32824173	909	917	Patients	Species	9606
32824173	936	955	emergence agitation	Disease	MESH:D000071257
32824173	997	1005	Delirium	Disease	MESH:D003693
32824173	1073	1084	sevoflurane	Chemical	MESH:D000077149
32824173	1114	1133	emergence agitation	Disease	MESH:D000071257
32824173	1163	1171	propofol	Chemical	MESH:D015742
32824173	1176	1185	ketorolac	Chemical	MESH:D020910
32824173	1198	1217	emergence agitation	Disease	MESH:D000071257
32824173	1307	1315	patients	Species	9606
32824173	1326	1334	propofol	Chemical	MESH:D015742
32824173	1339	1348	ketorolac	Chemical	MESH:D020910
32824173	1447	1455	patients	Species	9606
32824173	1470	1478	propofol	Chemical	MESH:D015742
32824173	1483	1492	ketorolac	Chemical	MESH:D020910
32824173	1616	1624	propofol	Chemical	MESH:D015742
32824173	1629	1638	ketorolac	Chemical	MESH:D020910
32824173	1661	1672	sevoflurane	Chemical	MESH:D000077149
32824173	1771	1790	emergence agitation	Disease	MESH:D000071257
32824173	Negative_Correlation	MESH:D020910	MESH:D000071257
32824173	Positive_Correlation	MESH:D000077149	MESH:D000071257
32824173	Cotreatment	MESH:D015742	MESH:D020910
32824173	Negative_Correlation	MESH:D000077149	MESH:D015742
32824173	Negative_Correlation	MESH:D015742	MESH:D000071257
32824173	Negative_Correlation	MESH:D000077149	MESH:D020910

